Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain

BSE407.40-0.65 (-0.16 %)

PREV CLOSE ( ) 408.05

OPEN PRICE ( ) 414.00

BID PRICE (QTY) 406.95 (29)

OFFER PRICE (QTY) 407.90 (9)

VOLUME 4627

TODAY'S LOW / HIGH ( )406.60 414.45

52 WK LOW / HIGH ( )235.6 581

NSE408.200.75 (+0.18 %)

PREV CLOSE( ) 407.45

OPEN PRICE ( ) 414.50

BID PRICE (QTY) 407.80 (1)

OFFER PRICE (QTY) 408.30 (1)

VOLUME 37529

TODAY'S LOW / HIGH( ) 405.00 414.50

52 WK LOW / HIGH ( )235.44 581.9

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

14.77

128.05

14493.56

-1450.30

-1773.44

Adjustment

-87.60

-958.69

-14549.67

2308.81

2530.44

Changes In working Capital

96.89

-3369.11

3008.63

219.08

-974.96

Cash Flow after changes in Working Capital

24.06

-4199.75

2952.52

1077.59

-217.96

Cash Flow from Operating Activities

-1.00

-4224.52

-1084.48

1067.64

-304.70

Cash Flow from Investing Activities

102.27

4303.31

12825.73

-476.79

-347.60

Cash Flow from Financing Activities

-28.08

-183.73

-11758.41

-471.10

907.39

Net Cash Inflow / Outflow

73.19

-104.94

-17.16

119.75

255.09

Opening Cash & Cash Equivalents

398.52

503.50

520.79

402.18

144.66

Cash & Cash Equivalent on Amalgamation / Take over / Merger

-1.14

2.43

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

0.03

-0.04

-0.13

Closing Cash & Cash Equivalent

471.74

398.52

503.50

520.79

402.18